kanamycin a has been researched along with Bacterial Skin Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzierzbicka, K; Kukowska, M; Kukowska-Kaszuba, M | 1 |
| Bes, M; Cavalié, L; Decousser, JW; Etienne, J; Laurent, F; Robert, J; Tristan, A | 1 |
2 other study(ies) available for kanamycin a and Bacterial Skin Diseases
| Article | Year |
|---|---|
In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections.
Topics: Anti-Infective Agents; Bacteremia; Escherichia coli; Fungi; Humans; Microbial Sensitivity Tests; Oligopeptides; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus aureus | 2015 |
Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Community-Acquired Infections; Enterotoxins; Exotoxins; France; Humans; Kanamycin; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Superantigens; Tetracycline; Tobramycin | 2011 |